Piero Andrea Temussi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Piero Andrea Temussi has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Delia Picone
Department of Chemical Sciences University of Naples Federico II Naples Italy
4 shared publications P. Amodeo
ICMIB del CNR, Arco Felice, Napoli, Italy
3 shared publications- Remo Guerrini
Department of Chemical, Pharmaceutical and Agricultural Sciences University of Ferrara 44100 Ferrara Italy
3 shared publications - Severo Salvadori
Department of Chemical and Pharmaceutical Sciences, University of Ferrara, 44121 Ferrara, Italy; Laboratorio per le tecnologie delle terapie avanzate (LTTA), University of Ferrara, 44121 Ferrara, Italy
3 shared publications - Roberta Spadaccini
Department of Science and Technology, Università degli Studi del Sannio, Benevento, Italy
2 shared publications T. Tancredi
2 shared publications
Latest Publications
- 13 July 1999
- Published by Wiley in Journal of Peptide Science
- Vol. 5 (7) , 306-312
Solution structure of dynorphin A (1-17): a NMR study in a cryoprotective solvent mixture at 278 K
Dynorphin A, the endogenous agonist for the κ opioid receptor, has been studied by NMR spectroscopy in methanol, acetonitrile, DMSO and in mixtures of hexafluoroacetone/water and DMSO/water. NMR data in the DMSO/water cryomixture at 278 K are consistent with a conformer in which the N‐terminal part, like the corresponding message domain of enkephalins, is poorly ordered, whereas the C‐terminal part is folded in a loop centred around Pro10. The folded structure of the C‐terminal part (address moiety) may shed light on the role of the essential residues Arg7, Lys11 and Lys13. Copyright © 1999 European Peptide Society and John Wiley & Sons, Ltd.
- 13 July 1999
- Published by Wiley in Journal of Peptide Science
- Vol. 5 (7) , 306-312
Solution structure of dynorphin A (1-17): a NMR study in a cryoprotective solvent mixture at 278 K
Dynorphin A, the endogenous agonist for the κ opioid receptor, has been studied by NMR spectroscopy in methanol, acetonitrile, DMSO and in mixtures of hexafluoroacetone/water and DMSO/water. NMR data in the DMSO/water cryomixture at 278 K are consistent with a conformer in which the N‐terminal part, like the corresponding message domain of enkephalins, is poorly ordered, whereas the C‐terminal part is folded in a loop centred around Pro10. The folded structure of the C‐terminal part (address moiety) may shed light on the role of the essential residues Arg7, Lys11 and Lys13. Copyright © 1999 European Peptide Society and John Wiley & Sons, Ltd.
- 3 November 1997
- Published by Wiley in FEBS Letters
- Vol. 417 (1) , 141-144
Design of μ selective opioid dipeptide antagonists
We have recently designed potent δ selective opioid antagonist dipeptides on the basis of a simple conformational analysis. Following a similar procedure we found a μ selective dipeptide antagonist, 2,6‐dimethyl‐Tyr‐d‐Phe‐NH2. Although its selectivity is not as high as those of the quoted δ selective dipeptides it has good in vitro activity and looks very promising for further development since the 2,6‐dimethyl‐Tyr‐D‐Phe message, like the δ selective 2,6‐dimethyl‐Tyr‐1,2,3,4‐tetrahydroisoquinoline‐3‐carboxylic acid counterpart, seems able to impart antagonism to longer peptides.
- 3 November 1997
- Published by Wiley in FEBS Letters
- Vol. 417 (1) , 141-144
Design of μ selective opioid dipeptide antagonists
We have recently designed potent δ selective opioid antagonist dipeptides on the basis of a simple conformational analysis. Following a similar procedure we found a μ selective dipeptide antagonist, 2,6‐dimethyl‐Tyr‐d‐Phe‐NH2. Although its selectivity is not as high as those of the quoted δ selective dipeptides it has good in vitro activity and looks very promising for further development since the 2,6‐dimethyl‐Tyr‐D‐Phe message, like the δ selective 2,6‐dimethyl‐Tyr‐1,2,3,4‐tetrahydroisoquinoline‐3‐carboxylic acid counterpart, seems able to impart antagonism to longer peptides.
- 28 April 1997
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 233 (3) , 640-643
Solution Conformation of Nociceptin
- 28 April 1997
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 233 (3) , 640-643
Solution Conformation of Nociceptin
- 27 December 1995
- Published by Wiley in FEBS Letters
- Vol. 377 (3) , 363-367
Conformational analysis of potent and very selective δ opioid dipeptide antagonists
The δ selectivity and antagonism of peptides containing l-tetrahydro-3-isoquinoline carboxylic acid (Tic) in second position can be attributed mainly to the Tyr-Tic unit. These properties can be further enhanced by substituting Tyr1 with 2,6-dimethyl-l-tyrosyl (Dmt). Dmt-Tic-NH2, Dmt-Tic-OH, Dmt-Tic-Ala-NH2 and Dmt-Tic-Ala-OH are all more active and/or selective than the corresponding [Tyr1]-parent peptides. In fact the selectivities of Dmt-Tic-OH and Dmt-Tic-Ala-OH are the highest ever recorded for opioid molecules. 1H NMR spectra in a DMSO/water mixture at 278 K reveal the presence of two similar conformers, characterised by a cis or trans Dmt-Tic bond, in all four peptides. A detailed conformational analysis in solution of Dmt-Tic-NH2 shows that these conformers have a shape very similar to that of the bioactive conformation of Tyr-Tic-NH2 and to that of naltrindole
- 27 December 1995
- Published by Wiley in FEBS Letters
- Vol. 377 (3) , 363-367
Conformational analysis of potent and very selective δ opioid dipeptide antagonists
The δ selectivity and antagonism of peptides containing l-tetrahydro-3-isoquinoline carboxylic acid (Tic) in second position can be attributed mainly to the Tyr-Tic unit. These properties can be further enhanced by substituting Tyr1 with 2,6-dimethyl-l-tyrosyl (Dmt). Dmt-Tic-NH2, Dmt-Tic-OH, Dmt-Tic-Ala-NH2 and Dmt-Tic-Ala-OH are all more active and/or selective than the corresponding [Tyr1]-parent peptides. In fact the selectivities of Dmt-Tic-OH and Dmt-Tic-Ala-OH are the highest ever recorded for opioid molecules. 1H NMR spectra in a DMSO/water mixture at 278 K reveal the presence of two similar conformers, characterised by a cis or trans Dmt-Tic bond, in all four peptides. A detailed conformational analysis in solution of Dmt-Tic-NH2 shows that these conformers have a shape very similar to that of the bioactive conformation of Tyr-Tic-NH2 and to that of naltrindole
- 1 June 1993
- Published by Wiley in Biopolymers
- Vol. 33 (6) , 915-926
Synthesis, biological activity, and conformational analysis of [pGlu6, N‐MePhe8, Aib9] substance P (6–11): A selective agonist for the NK‐3 receptor
A highly potent and selective agonist to the tachykinin NK-3 receptor, [pGlu6, N-MePhe8, Aib9] substance P (6–11) (I), was synthesized via the solid phase method. The ED50 of I was 4n M in the guinea pig ileum in the absence of atropine (NK-1 + NK-3 receptors) and this agonist was 5000-fold less potent in the presence of atropine (NK-1 receptor). The analogue was virtually inactive in the rat vas deferens (NK-2 receptor). A detailed analysis of the solution conformation of this analogue in DMSO-d6 and in a DMSO-d6 H2O cryornixture was carried out by a combination of 1H-nmr 2D techniques (DQF-COSY, TOCSY, NOESY and ROESY) and model building based on empirical energy calculations. Peptide I exists as a mixture of isomers containing cis and trans Phe-N-MePhe peptide bonds. The main isomer, containing a cis Phe-N-MePhe peptide bond, shows a preferred folded conformation characterized by a type VI β-turn with Phe and N-MePhe in the i + 1 and i + 2 positions. The turn is followed by a helical segment extending to the C-terminal. This conformation is compared to previously reported conformations of other selective tachykinin agonists and may be a promising lead for the design of novel NK-3 agonists with additional conformational constraints. © 1993 John Wiley & Sons, Inc.
- 1 June 1993
- Published by Wiley in Biopolymers
- Vol. 33 (6) , 915-926
Synthesis, biological activity, and conformational analysis of [pGlu6, N‐MePhe8, Aib9] substance P (6–11): A selective agonist for the NK‐3 receptor
A highly potent and selective agonist to the tachykinin NK-3 receptor, [pGlu6, N-MePhe8, Aib9] substance P (6–11) (I), was synthesized via the solid phase method. The ED50 of I was 4n M in the guinea pig ileum in the absence of atropine (NK-1 + NK-3 receptors) and this agonist was 5000-fold less potent in the presence of atropine (NK-1 receptor). The analogue was virtually inactive in the rat vas deferens (NK-2 receptor). A detailed analysis of the solution conformation of this analogue in DMSO-d6 and in a DMSO-d6 H2O cryornixture was carried out by a combination of 1H-nmr 2D techniques (DQF-COSY, TOCSY, NOESY and ROESY) and model building based on empirical energy calculations. Peptide I exists as a mixture of isomers containing cis and trans Phe-N-MePhe peptide bonds. The main isomer, containing a cis Phe-N-MePhe peptide bond, shows a preferred folded conformation characterized by a type VI β-turn with Phe and N-MePhe in the i + 1 and i + 2 positions. The turn is followed by a helical segment extending to the C-terminal. This conformation is compared to previously reported conformations of other selective tachykinin agonists and may be a promising lead for the design of novel NK-3 agonists with additional conformational constraints. © 1993 John Wiley & Sons, Inc.
- 31 March 1993
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 191 (3) , 853-859
Solution Structure of Casokefamide
- 31 March 1993
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 191 (3) , 853-859
Solution Structure of Casokefamide